Felis ISSN 2398-2950

Mupirocin

Synonym(s): Pseudominic acid

Contributor(s): Yolande Bishop, Vetstream Ltd

Introduction

Name

  • Mupirocin.

Class of drug

  • Antibacterial agent.

Description

Chemical name

  • [2S-[2alpha(E),3beta,4beta,5alpha[2R*,3R*(1R*,2R*)]]]-9-[[3-methyl-1-oxo-4-[tetrahydro-3,4-dihydroxy-5-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy]nonanoic acid.

Molecular formula

  • C26, H44, O9.

Molecular weight

  • 500.63.

Physical properties

  • Crystalline.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Bacterial skin infections.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMed Resource.
  • Harbarth S et al (1999) Randomized, placebo-controlled, double-blind trial to evaulate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43(6) 1412-1416.
  • Williford P M (1999) Opportunities for mupirocin calcium cream in the emergency department. J Emerg Med 17(1) 213-220.
  • Riu S et al (1998) Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 13(7) 1870-1871.
  • Cookson B D (1998) The emergence of mupirocin resistance - a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41(1) 11-18.
  • Goldfarb J (1995) New antimicrobial agents. Pediatr Clin North Am 42(3) 717-735.
  • Vizcaino-Alcaide M  Jet al(1993) Efficacy of a broad-spectrum antibiotic (mupirocin) in an in vitro model of infected skin. Burns 19(5) 392-295.
  • Leyden J J (1992) Review of mupirocin ointment in the treatment of impetigo. Clin Pediatr (Phila) 31(9) 549-553.
  • Czarnecki D et al (1992) Prevention of post-excisional wound infections - a comparison of oral cephalexin with topical mupirocin and topical cetrimide-chlorhexidine cream. Int J Dermatol 31(5) 359-360.
  • Lamb Y J (1991) Overview of the role of mupirocin. J Hosp Infect 19(Suppl. B) 27-30.
  • Johnston C (1991) Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 24(5-1) 797-798.

Other sources of information

  • Tennant, B (1999) Small Animal Formulary. 3rd edn. Cheltenham: British Small Animal Veterinary Association. ISBN: 0 9052 1452 8.

ADDED